Grifols reported EUR156.07M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
GlaxoSmithKline GBP 167M 17M Sep/2025
Grifols EUR 156.07M 31.46M Sep/2025